Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

SAREPTA THERAPEUTICS, INC.

Filed by SAREPTA THERAPEUTICS, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-15 06:26:11 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
Not reported
Expenses
$220,000.00
Filing UUID
944a9a08-7e31-419b-a2c8-ae9e2f1e01ea
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

H.R. 9260 - LHHS Appropriations

Literal federal measure citations: H.R. 9260

HCR · Health Issues

H.R. 1509 - Accelerating Kids Access to Care Act Patient Access Act Issues related to patient access to treatment

Literal federal measure citations: H.R. 1509

SCI · Science/Technology

National Security Commission on emerging biotechnology policy proposals

TRD · Trade (domestic/foreign)

Issues related to supply chain Issues related to Section 232

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.